Department of Diabetes, Endocrinology and Nutrition, Hospital of Sabadell, Corporació Sanitària i Universitària Parc Taulí (Universitat Autònoma de Barcelona), 08208 Sabadell, Spain.
Diabetes Metab. 2013 Sep;39(4):355-62. doi: 10.1016/j.diabet.2013.03.006. Epub 2013 May 3.
This study investigated the relationship between endothelial dysfunction (ED) and arterial stiffness (AS) in adults with type 1 diabetes and no clinical cardiovascular (CV) disease.
A total of 68 patients with type 1 diabetes and 68 age- and gender-matched healthy (non-diabetic) subjects were evaluated. ED was assessed by reactive hyperaemia peripheral arterial tonometry (RH-PAT) and by serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and E-selectin. AS was assessed by aortic pulse wave velocity (aPWV). All statistical analyses were stratified by gender.
Adults with type 1 diabetes had RH-PAT index scores similar to those of their matching controls [men: 1.55 (1.38-1.98)% versus 1.61 (1.40-2.17)%, P=0.556; women: 2.07 (1.55-2.31)% versus 2.08 (1.79-2.49)%; P=0.215]. However, after adjusting for potential confounders, type 1 diabetes emerged as the main determinant of the RH-PAT index in women. Also, differences between genders in both the controls and type 1 diabetes patients disappeared. Men with diabetes had higher serum concentrations of E-selectin, and women had higher serum concentrations of sICAM-1, sVCAM-1 and E-selectin than their respective controls. However, after adjusting for potential confounders, only the differences in sICAM-1 (women) and E-selectin (both genders) remained significant. No association was found between aPWV and the RH-PAT index and ED markers after adjusting for CV risk factors.
ED was increased in adults with type 1 diabetes compared with age-matched non-diabetic subjects. Also, gender differences in ED were lost in type 1 diabetes. However, ED was not associated with AS after adjusting for potential confounders. These findings suggest that ED occurs earlier than AS in type 1 diabetes.
本研究旨在探讨 1 型糖尿病且无临床心血管疾病的成年人中内皮功能障碍(ED)与动脉僵硬度(AS)之间的关系。
共评估了 68 例 1 型糖尿病患者和 68 名年龄和性别匹配的健康(非糖尿病)对照者。通过反应性充血外周动脉张力测定法(RH-PAT)和血清可溶性细胞间黏附分子-1(sICAM-1)、可溶性血管细胞黏附分子-1(sVCAM-1)和 E-选择素浓度评估 ED。通过主动脉脉搏波速度(aPWV)评估 AS。所有统计分析均按性别分层。
1 型糖尿病患者的 RH-PAT 指数评分与匹配对照组相似[男性:1.55(1.38-1.98)%与 1.61(1.40-2.17)%,P=0.556;女性:2.07(1.55-2.31)%与 2.08(1.79-2.49)%;P=0.215]。然而,在校正潜在混杂因素后,1 型糖尿病成为女性 RH-PAT 指数的主要决定因素。此外,对照组和 1 型糖尿病患者的性别差异也消失了。糖尿病男性的血清 E-选择素浓度较高,而女性的血清 sICAM-1、sVCAM-1 和 E-选择素浓度高于各自的对照组。然而,在校正潜在混杂因素后,只有 sICAM-1(女性)和 E-选择素(两性)的差异仍具有显著性。校正心血管危险因素后,aPWV 与 RH-PAT 指数和 ED 标志物之间无相关性。
与年龄匹配的非糖尿病患者相比,1 型糖尿病患者的 ED 增加。此外,1 型糖尿病患者的 ED 性别差异消失。然而,校正潜在混杂因素后,ED 与 AS 无关。这些发现表明,在 1 型糖尿病中,ED 发生早于 AS。